What question did this study set out to answer?

To analyze and compare the disease burden of pulmonary arterial hypertension in China and India from 1990 to 2021.

December 11, 2025Open Access

The trend analysis and comparison of pulmonary arterial hypertension disease burden in China and India from 1990 to 2021: a study based on the Global Burden of Disease 2021 database

Key Points

To analyze and compare the disease burden of pulmonary arterial hypertension in China and India from 1990 to 2021.
Trend analysis of data from the Global Burden of Disease 2021 database
Comparison between China and India populations
Focus on screening and diagnosis interventions
Pulmonary arterial hypertension remains a severe health issue in both countries
China shows a significant disease burden among middle-aged and elderly populations
India highlights the need for improved diagnosis and screening in children under 5 years old

Abstract

Both China and India have large populations, and the disease burden of PAH remains severe. China should focus on strengthening screening interventions for PAH in the middle-aged and elderly populations, while India should particularly focus on strengthening screening and diagnosis for PAH in children under 5 years old to reduce mortality.

Read Full Paperexternally

Ask AI

Helpful

Bookmark

View Full Paper